PHASE 2 STUDY OF PEMBROLIZUMAB PLUS TTFIELDS PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (2-THE-TOP)

被引：0
|
作者：
Tran, David [1 ]
Ghinaseddin, Ashley [2 ]
Chen, Dongjiang [2 ]
Rahman, Maryam [2 ]
机构：
[1] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA
[2] Univ Florida, Gainesville, FL USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTIM-16
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [21] AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
    Chinot, O. L.
    Rouge, T. de la Motte
    Moore, N.
    Zeaiter, A.
    Das, A.
    Phillips, H.
    Modrusan, Z.
    Cloughesy, T.
    ADVANCES IN THERAPY, 2011, 28 (04) : 334 - 340
  • [22] AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
    O. L. Chinot
    T. de La Motte Rouge
    N. Moore
    A. Zeaiter
    A. Das
    H. Phillips
    Z. Modrusan
    T. Cloughesy
    Advances in Therapy, 2011, 28 : 334 - 340
  • [23] Anlotinib plus radiotherapy-temozolomide for newly diagnosed glioblastoma: A prospective, multicenter phase II study.
    Lai, Shuzhen
    Chen, Yuan Yuan Yuan
    Li, Peijing
    Jiang, Fagui
    Liu, Xiaohui
    Tao, Changjuan
    Huang, Jing
    Tang, Yiqiang
    Liu, Zhigang
    Shen, Guoping
    Li, Chaoming
    Xie, Tieming
    Lu, Fangxiao
    Liu, Guihong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma
    Maraka, Stefania
    Groves, Morris D.
    Mammoser, Aaron G.
    Melguizo-Gavilanes, Isaac
    Conrad, Charles A.
    Tremont-Lukats, Ivo W.
    Loghin, Monica E.
    Obrien, Barbara J.
    Puduvalli, Vinay K.
    Sulman, Erik P.
    Hess, Kenneth R.
    Aldape, Kenneth D.
    Gilbert, Mark R.
    de Groot, John F.
    Yung, W. K. Alfred
    Penas-Prado, Marta
    CANCER, 2019, 125 (03) : 424 - 433
  • [25] Radiologic progression types are treatment specific: An exploratory analysis of a phase 3 study of bevacizumab plus radiotherapy plus temozolomide for patients with newly diagnosed glioblastoma (AVAglio).
    Nowosielski, Martha
    Chinott, Olivier L.
    Radbrucht, Alexander
    Stockhammer, Guenther
    Garcia, Josep
    Revil, Cedric
    Nishikawa, Ryo
    Mason, Warren P.
    Henriksson, Roger
    Saran, Frank
    Bendszus, Martin
    Abrey, Lauren E.
    Cloughesy, Timothy Francis
    Wick, Wolfgang
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaros Lazaridis
    Niklas Schäfer
    Sarah Teuber-Hanselmann
    Tobias Blau
    Teresa Schmidt
    Christoph Oster
    Johannes Weller
    Theophilos Tzaridis
    Daniela Pierscianek
    Kathy Keyvani
    Christoph Kleinschnitz
    Martin Stuschke
    Björn Scheffler
    Cornelius Deuschl
    Ulrich Sure
    Ulrich Herrlinger
    Sied Kebir
    Martin Glas
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 787 - 792
  • [27] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaridis, Lazaros
    Schaefer, Niklas
    Teuber-Hanselmann, Sarah
    Blau, Tobias
    Schmidt, Teresa
    Oster, Christoph
    Weller, Johannes
    Tzaridis, Theophilos
    Pierscianek, Daniela
    Keyvani, Kathy
    Kleinschnitz, Christoph
    Stuschke, Martin
    Scheffler, Bjoern
    Deuschl, Cornelius
    Sure, Ulrich
    Herrlinger, Ulrich
    Kebir, Sied
    Glas, Martin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 787 - 792
  • [28] Randomized Phase II trial of Tumor Treating Fields plus radiation therapy plus temozolamide compared to radiation therapy plus temozolomide in patients with newly diagnosed glioblastoma
    Grossman, Rachel
    Limon, Dror
    Bokstein, Felix
    Ben Harosh, Carmit
    Ram, Zvi
    CANCER RESEARCH, 2019, 79 (13)
  • [29] Temozolomide plus bevacizumab in elderly patients with newly diagnosed glioblastoma and poor performance status: An Anocef phase II trial
    Reyes-Botero, German
    Honnorat, Jerome
    Chinot, Oliver L.
    Taillandier, Luc
    Catry-Thomas, Isabelle
    Barriere, Jerome
    Guillamo, Jean Sebastien
    Fabbro, Michel
    Frappaz, Didier
    Amiel, Alexandra Benouaich
    Le Rhun, Emilie
    Campello, Chantal
    Tennevet, Isabelle
    Ghiringhelli, Francois
    Tanguy, Marie-Laure
    Mokhtari, Karima
    Delattre, Jean-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
    Butowski, Nicholas
    Chang, Susan M.
    Lamborn, Kathleen R.
    Polley, Mei-Yin
    Pieper, Russell
    Costello, Joseph F.
    Vandenberg, Scott
    Parvataneni, Rupa
    Nicole, Angelina
    Sneed, Patricia K.
    Clarke, Jennifer
    Hsieh, Emily
    Costa, Bruno M.
    Reis, Rui M.
    Hristova-Kazmierski, Maria
    Nicol, Steven J.
    Thornton, Donald E.
    Prados, Michael D.
    NEURO-ONCOLOGY, 2011, 13 (12) : 1331 - 1338
12345